FollowMyHealth Patient Portal

Charles R. Conway, MD

Professor, Psychiatry

Specialty Areas

Adult Psychiatry
Mood Disorders
Depression

Board Certifications

Psychiatry

Hospital Affiliations

Barnes-Jewish Hospital

Areas of Clinical Interest

Vagus nerve stimulation for treatment resistant depression, bipolar disorder, mood disorders.

  • Maps & Directions
  • Education
  • Publication & Research

Maps & Directions

Maps & Directions

Barnes-Jewish Hospital

1 Barnes-Jewish Hospital Plaza
St. Louis, MO 63110

Office Phone: 314-286-1700
Fax: 314-362-7017

Education

Education

B.A.: Psychology, St. Louis University, St. Louis, Missouri 1987
Medical Degree: University of Missouri-Columbia, Columbia, Missouri 1995
Residency: Psychiatry, Duke University Medical Center, Durham, North Carolina 1999

Publication & Research

Publication & Research

Sustained remission in patients with treatment-resistant depression receiving vagal nerve stimulation: A case series.
Salloum NC, Gott BM, Conway CR
Brain Stimul. 2017 Jun 8; pii: S1935-861X(17)30828-8. doi: 10.1016/j.brs.2017.06.001.

PMID:
    28645560
    [PubMed - as supplied by publisher]
Related citations


Defining Treatment-Resistant Depression-Reply.
Conway CR, George MS, Sackeim HA
JAMA Psychiatry. 2017 Jul 1; 74(7)759. doi: 10.1001/jamapsychiatry.2017.0970.

PMID:
    28564688
    [PubMed - in process]
Related citations


A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality.
Aaronson ST, Sears P, Ruvuna F, Bunker M, Conway CR, Dougherty DD, Reimherr FW, Schwartz TL, Zajecka JM
Am J Psychiatry. 2017 Jul 1; 174(7)640-648. doi: 10.1176/appi.ajp.2017.16010034.

PMID:
    28359201
    [PubMed - indexed for MEDLINE]
Related citations


Use of Ketamine in Clinical Practice: A Time for Optimism and Caution.
Zorumski CF, Conway CR
JAMA Psychiatry. 2017 Apr 1; 74(4)405-406. doi: 10.1001/jamapsychiatry.2017.0078.

PMID:
    28249064
    [PubMed - in process]
Related citations


Emergence of mania in two middle-aged patients with a history of unipolar treatment-refractory depression receiving vagus nerve stimulation.
Salloum NC, Walker MC, Gangwani S, Conway CR
Bipolar Disord. 2017 Feb; 19(1)60-64. doi: 10.1111/bdi.12463.

PMID:
    28098427
    [PubMed - in process]
Related citations


Toward an Evidence-Based, Operational Definition of Treatment-Resistant Depression: When Enough Is Enough.
Conway CR, George MS, Sackeim HA
JAMA Psychiatry. 2017 Jan 1; 74(1)9-10. doi: 10.1001/jamapsychiatry.2016.2586.

PMID:
    27784055
    [PubMed - in process]
Related citations


Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy.
Zorumski CF, Nagele P, Mennerick S, Conway CR
Front Psychiatry. 2015; 6172. doi: 10.3389/fpsyt.2015.00172.

PMID:
    26696909
    [PubMed]
Related citations


Clinical characteristics and management of treatment-resistant depression.
Conway CR, Gebara MA, Walker MC, Lessov-Schlaggar CN, Janski AM, Chibnall JT, Cristancho P, Sheline YI, Gott BM, Svrakic DM
J Clin Psychiatry. 2015 Nov; 76(11)1569-70. doi: 10.4088/JCP.14l09462.

PMID:
    26646033
    [PubMed - indexed for MEDLINE]
Related citations


Nitrous Oxide for Treatment-Resistant Major Depression: A Proof-of-Concept Trial.
Nagele P, Duma A, Kopec M, Gebara MA, Parsoei A, Walker M, Janski A, Panagopoulos VN, Cristancho P, Miller JP, Zorumski CF, Conway CR
Biol Psychiatry. 2015 Jul 1; 78(1)10-8. doi: 10.1016/j.biopsych.2014.11.016.

PMID:
    25577164
    [PubMed - indexed for MEDLINE]
Related citations


Antidepressant response to aripiprazole augmentation associated with enhanced FDOPA utilization in striatum: a preliminary PET study.
Conway CR, Chibnall JT, Cumming P, Mintun MA, Gebara MA, Perantie DC, Price JL, Cornell ME, McConathy JE, Gangwani S, Sheline YI
Psychiatry Res. 2014 Mar 30; 221(3)231-9. doi: 10.1016/j.pscychresns.2014.01.003.

PMID:
    24468015
    [PubMed - indexed for MEDLINE]
Related citations


Association of cerebral metabolic activity changes with vagus nerve stimulation antidepressant response in treatment-resistant depression.
Conway CR, Chibnall JT, Gebara MA, Price JL, Snyder AZ, Mintun MA, Craig AD, Cornell ME, Perantie DC, Giuffra LA, Bucholz RD, Sheline YI
Brain Stimul. 2013 Sep; 6(5)788-97. doi: 10.1016/j.brs.2012.11.006.

PMID:
    23485649
    [PubMed - indexed for MEDLINE]
Related citations


Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects.
Aaronson ST, Carpenter LL, Conway CR, Reimherr FW, Lisanby SH, Schwartz TL, Moreno FA, Dunner DL, Lesem MD, Thompson PM, Husain M, Vine CJ, Banov MD, Bernstein LP, Lehman RB, Brannon GE, Keepers GA, O'Reardon JP, Rudolph RL, Bunker M
Brain Stimul. 2013 Jul; 6(4)631-40. doi: 10.1016/j.brs.2012.09.013.

PMID:
    23122916
    [PubMed - indexed for MEDLINE]
Related citations


Pretreatment cerebral metabolic activity correlates with antidepressant efficacy of vagus nerve stimulation in treatment-resistant major depression: a potential marker for response?
Conway CR, Chibnall JT, Gangwani S, Mintun MA, Price JL, Hershey T, Giuffra LA, Bucholz RD, Christensen JJ, Sheline YI
J Affect Disord. 2012 Aug; 139(3)283-90. doi: 10.1016/j.jad.2012.02.007.

PMID:
    22397889
    [PubMed - indexed for MEDLINE]
Related citations


Brain blood-flow change with acute vagus nerve stimulation in treatment-refractory major depressive disorder.
Conway CR, Sheline YI, Chibnall JT, Bucholz RD, Price JL, Gangwani S, Mintun MA
Brain Stimul. 2012 Apr; 5(2)163-71. doi: 10.1016/j.brs.2011.03.001.

PMID:
    22037127
    [PubMed - indexed for MEDLINE]
Related citations


Marked Response to VNS in a Post-Cingulotomy Patient: Implications for the Mechanism of Action of VNS in TRD.
Conway CR, Gebretsadik MD, Bucholz RD
CNS Spectr. 2011 Jun; 16(6)135-41. doi: 10.1017/S1092852912000302.

PMID:
    24725456
    [PubMed]
Related citations


Vagus nerve stimulation for depression: a case of a broken lead, depression relapse, revision surgery, and restoration of patient response.
Conway CR, Chibnall JT, Tait RC
Brain Stimul. 2008 Jul; 1(3)227-8. doi: 10.1016/j.brs.2008.05.003.

PMID:
    20633388
    [PubMed - indexed for MEDLINE]
Related citations


Ephedrine-induced emergence of bipolar symptoms.
Conway CR, Ziaee L, Langenfeld SJ
Bipolar Disord. 2006 Apr; 8(2)204-5.

PMID:
    16542194
    [PubMed - indexed for MEDLINE]
Related citations


Cerebral blood flow changes during vagus nerve stimulation for depression.
Conway CR, Sheline YI, Chibnall JT, George MS, Fletcher JW, Mintun MA
Psychiatry Res. 2006 Mar 31; 146(2)179-84.

PMID:
    16510266
    [PubMed - indexed for MEDLINE]
Related citations


An open-label trial of adjunctive oxcarbazepine for bipolar disorder.
Conway CR, Chibnall JT, Nelson LA, McGuire JM, Abraham PF, Baram VY, Grossberg GT, Carroll BJ
J Clin Psychopharmacol. 2006 Feb; 26(1)95-7.

PMID:
    16415718
    [PubMed - indexed for MEDLINE]
Related citations


Nefazodone-induced liver failure.
Conway CR, McGuire JM, Baram VY
J Clin Psychopharmacol. 2004 Jun; 24(3)353-4.

PMID:
    15118496
    [PubMed - indexed for MEDLINE]
Related citations

Areas of Research Interest

Mood disorders, treatment-resistant depression, mechanism of action of neurostimulation treatments, and bipolar disorders.